Tetrahydrobiopterin protects soluble guanylate cyclase against oxidative inactivation
Tetrahydrobiopterin (BH4) is a major endogenous vasoprotective agent that improves endothelial function by increasing nitric oxide (NO) synthesis and scavenging of superoxide and peroxynitrite. Accordingly, administration of BH4 is considered as a promising therapy of cardiovascular diseases associa...
| Główni autorzy: | , , |
|---|---|
| Format: | Artykuł |
| Język: | English |
| Wydane: |
De Gruyter
2013-06-01
|
| Seria: | Pteridines |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1515/pterid-2013-0015 |